483 Jiangsu Jiaerke Pharmaceuticals Group Jul 2018

483 Jiangsu Jiaerke Pharmaceuticals Group Jul 2018

$119 - Not in Stock

FDA investigators audited the Jiangsu Jiaerke Pharmaceuticals Group - Changzhou, China facility and issued inspectional observations (via FDA 483) on 26 Jul 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Jul 2018
  • Location: Changzhou, China
  • FEI: 3001599766

Pre-Order Not Available